24 Results for "

HIV-1 latency

" in MedChemExpress (MCE) Product Catalog:
Products (24)

24 Results for "HIV-1 latency" in MCE Product Catalog:

89
89 Publications Verification
Cat. No.: HY-10224
CAS No.: 404950-80-7
Purity:  99.37%
Synonyms: LBH589; NVP-LBH589
Target:  

HDAC Autophagy HIV Apoptosis

Research Areas:  

Cancer

Panobinostat (LBH589; NVP-LBH589) is a potent and orally active non-selective HDAC inhibitor, and has antineoplastic activities . Panobinostat induces HIV-1 virus production even at low concentration range 8-31 nM, stimulates HIV-1 expression in latently infected cells . Panobinostat induces cell apoptosis and autophagy. Panobinostat can be used for the study of refractory or relapsed multiple myeloma .
loading...
    loading...
26
26 Cited Publications
Cat. No.: HY-13207
CAS No.: 960374-59-8
Purity:  99.72%
Synonyms: PR-957
Target:  

Proteasome Bacterial HIV

Research Areas:  

Infection Inflammation/Immunology

ONX-0914 (PR-957) is a selective inhibitor of low-molecular mass polypeptide-7 (LMP7), the chymotrypsin-like subunit of the immunoproteasome. ONX-0914 blocks cytokine production and attenuates progression of experimental arthritis. ONX-0914 is a noncompetitive irreversible inhibitor of the mycobacterial proteasome (Ki=5.2 μM). ONX-0914 reactivates latent HIV-1 through p-TEFb activation mediated by HSF-1 .
loading...
    loading...
26
26 Cited Publications
Cat. No.: HY-13207A
Purity:  98.01%
Synonyms: PR-957 TFA
Target:  

Proteasome Bacterial HIV

Research Areas:  

Infection Inflammation/Immunology

ONX-0914 (PR-957) TFA is a selective inhibitor of low-molecular mass polypeptide-7 (LMP7), the chymotrypsin-like subunit of the immunoproteasome. ONX-0914 TFA blocks cytokine production and attenuates progression of experimental arthritis. ONX-0914 TFA is a noncompetitive irreversible inhibitor of the mycobacterial proteasome (Ki=5.2 μM). ONX-0914 TFA reactivates latent HIV-1 through p-TEFb activation mediated by HSF-1 .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-15815
CAS No.: 1619994-69-2
Purity:  99.89%
Research Areas:  

Cancer

Bromosporine, a chemical probe, is a potent BET inhibitor with an IC50 value of 2.1 μM for PCAF. Bromosporine can arrest cell cycle and induce apoptosis in cancer cells. Bromosporine exhibits excellent antitumor activity in xenograft mice model when combined with 5-Fluorouracil (HY-90006). Bromosporine can increase CDK9 T-loop phosphorylation in HIV-1 latency models, resulting the protection of reactivate HIV-1 replication from latency. Bromosporine can be used to research colorectal cancer, acute myeloid leukemia (AML) and AIDS .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-114268
CAS No.: 1357647-78-9
Purity:  98.42%
Target:  

HIV

Research Areas:  

Infection

BRD-K98645985 is a BAF (mammalian SWI/SNF) transcriptional repression inhibitor with an EC50 of ~2.37 μM. BRD-K98645985 binds ARID1A-specific BAF complexes, prevents nucleosomal positioning, and potently reverses HIV-1 latency, without T cell activation or toxicity .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-A0068
CAS No.: 12192-57-3
Synonyms: Gold thioglucose
Aurothioglucose (Gold thioglucose), containing monovalent gold ion, is a potent active-site inhibitor of TrxR1 (thioredoxin reductase 1), with an IC50 of 65 nM. Aurothioglucose inhibits the DNA binding of NF-κB in vitro. Aurothioglucose shows anti-HIV and anti-rheumatic activities .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-19618
CAS No.: 1550053-02-5
Target:  

HDAC HIV Apoptosis

Research Areas:  

Infection Metabolic Disease

BRD3308 is a highly selective HDAC3 inhibitor with an IC50 of 54 nM. BRD3308 is 23-fold selectivity for HDAC3 over HDAC1 (IC50 of 1.26 μM) or HDAC2 (IC50 of 1.34 μM). BRD3308 suppresses pancreatic β-cell apoptosis induced by inflammatory cytokines or glucolipotoxic stress, and increases functional insulin release. BRD3308 activates HIV-1 transcription and disrupts HIV-1 latency .
loading...
    loading...
Cat. No.: HY-130514
CAS No.: 327081-00-5
Target:  

HIV CDK

Research Areas:  

Infection

SMAPP1 is an activator of protein phosphatase-1 (PP1). SMAPP1 increases phosphorylation of CDK9’s Ser90 and Thr186 residues, but not Ser175. SMAPP1 induces HIV-1 replication, upregulates HIV-1 transcription that led to the reactivation of latent HIV-1 provirus .
loading...
    loading...
Cat. No.: HY-10224R
CAS No.: 404950-80-7
Synonyms: LBH589 (Standard); NVP-LBH589 (Standard)
Research Areas:  

Infection Cancer

Panobinostat (Standard) (LBH589 (Standard)) is the analytical standard of Panobinostat (HY-10224). This product is intended for research and analytical applications. Panobinostat is a potent and orally active non-selective HDAC inhibitor, and has antineoplastic activities . Panobinostat induces HIV-1 virus production even at low concentration range 8-31 nM, stimulates HIV-1 expression in latently infected cells . Panobinostat induces cell apoptosis and autophagy. Panobinostat can be used for the study of refractory or relapsed multiple myeloma .
loading...
    loading...
Cat. No.: HY-10224S
CAS No.: 1185237-51-7
Synonyms: LBH589-d4; NVP-LBH589-d4
Panobinostat-d4 is the deuterium labeled Panobinostat. Panobinostat (LBH589; NVP-LBH589) is a potent and orally active non-selective HDAC inhibitor, and has antineoplastic activities[1][2]. Panobinostat induces HIV-1 virus production even at low concentration range 8-31 nM, stimulates HIV-1 expression in latently infected cells[4]. Panobinostat induces cell apoptosis and autophagy. Panobinostat can be used for the study of refractory or relapsed multiple myeloma[3].
loading...
    loading...
Cat. No.: HY-10224S1
Synonyms: LBH589-d4 hydrochloride; NVP-LBH589-d4 hydrochloride
Panobinostat-d4 (hydrochloride) is deuterium labeled Panobinostat. Panobinostat (LBH589; NVP-LBH589) is a potent and orally active non-selective HDAC inhibitor, and has antineoplastic activities[1][2]. Panobinostat induces HIV-1 virus production even at low concentration range 8-31 nM, stimulates HIV-1 expression in latently infected cells[4]. Panobinostat induces cell apoptosis and autophagy. Panobinostat can be used for the study of refractory or relapsed multiple myeloma[3].
loading...
    loading...
Cat. No.: HY-163666
Target:  

HIV PKC

Research Areas:  

Infection

HIV-1 inhibitor-68 (compound 26) is a protein kinase C (PKC) activator derivative with reversal activity in HIV-1 latency. HIV-1 inhibitor-68 may be able to eliminate cells latently infected with HIV-1, .
loading...
    loading...
Cat. No.: HY-162077
CAS No.: 2413866-14-3
Target:  

HIV

Research Areas:  

Infection

HIV-IN-10 is a HIV-1 latency reversing agent .
loading...
    loading...
Cat. No.: HY-147553
CAS No.: 2170506-18-8
Target:  

HIV

Research Areas:  

Infection

HIV-1 inhibitor-36 (Compound 2) is a potent HIV-1. HIV-1 inhibitor-36 has the potential for further development as novel latency reversing agents .
loading...
    loading...
Cat. No.: HY-147554
CAS No.: 2416971-40-7
Target:  

HIV

Research Areas:  

Infection

HIV-1 inhibitor-37 (Compound 83) is a potent HIV-1. HIV-1 inhibitor-37 has the potential for further development as novel latency reversing agents .
loading...
    loading...
Cat. No.: HY-147555
CAS No.: 2416971-48-5
Target:  

HIV

Research Areas:  

Infection

HIV-1 inhibitor-38 (Compound 91) is a potent HIV-1. HIV-1 inhibitor-38 has the potential for further development as novel latency reversing agents .
loading...
    loading...
Cat. No.: HY-155599
CAS No.: 2982527-11-5
Target:  

HIV PKC

Research Areas:  

Infection

HIV-1 protease-IN-10 (Compound 2) has HIV-1 latency reversing activity (IC50: 0.22 μM). HIV-1 protease-IN-10 binds to the PKCδ C1b domain (IC50: 0.69 μM). HIV-1 protease-IN-10 has stability against esterase-mediated hydrolysis .
loading...
    loading...
Cat. No.: HY-119490
CAS No.: 2109805-83-4
Research Areas:  

Infection

UMB-136 is a bromodomain inhibitor. UMB-136 is a promising latency-reversing agent (LRA) for HIV-1 eradication. UMB-136 reactivates HIV-1 in multiple cell models. UMB-136 enhances HIV-1 transcription and increases viral production through the release of P-TEFb .
loading...
    loading...
Cat. No.: HY-147552
CAS No.: 2416971-32-7
Target:  

HIV

Research Areas:  

Infection

HIV-1 inhibitor-35 (compound 74) is a potent HIV-1 inhibitor with EC50s of 80 nM and 70 nM for LTR and CMV in HEK293 cells, respectively. HIV-1 inhibitor-35 has inhibitory activity against liver cancer cell HepG2 with a CC50 of 40 nM. HIV-1 inhibitor-35 can be used as HIV-1 latency reversing agent .
loading...
    loading...
Cat. No.: HY-134844
CAS No.: 2433895-70-4
Synonyms: SBI-0953294
Target:  

HIV IAP NF-κB

Research Areas:  

Infection

Ciapavir (SBI-0953294) is a HIV-1 latency-reversing agent. Ciapavir reverses latent HIV-1 reservoir in vitro and in vivo without inducing systemic T cell activation or broad cytokine release. Ciapavir degrades cIAP1 and activates non-canonical NF-κB pathway. Ciapavir can be used for the research of HIV-1 infection .
loading...
    loading...